These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 2150026

  • 21. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
    Limbs International Medicinal Buflomedil (LIMB) Study Group, Leizorovicz A, Becker F.
    Circulation; 2008 Feb 12; 117(6):816-22. PubMed ID: 18212283
    [Abstract] [Full Text] [Related]

  • 22. [Intra-arterial infusion therapy in thrombo-obliterating diseases of the lower limbs].
    Kurbangaleev SM, Savel'ev IuS.
    Vestn Khir Im I I Grek; 1974 Oct 12; 113(10):68-71. PubMed ID: 4432347
    [No Abstract] [Full Text] [Related]

  • 23. [Effect of papaveroline on chronic, obliterating, peripheral arterial diseases].
    Sironi G, Benedetti G.
    Minerva Cardioangiol; 1973 Apr 12; 21(4):257-63. PubMed ID: 4710122
    [No Abstract] [Full Text] [Related]

  • 24. [Physiopathology and therapy of obliterating arteriopathies].
    Schettler G, Mörl H.
    Clin Ter; 1979 Jan 15; 88(1):3-19. PubMed ID: 436376
    [No Abstract] [Full Text] [Related]

  • 25. [Effectiveness of buflomedil in arterial occlusive disease. Modification of transcutaneous oxygen pressure in a placebo-controlled double-blind study].
    Sunder-Plassmann L, Gandolfo AM, Utz C.
    MMW Munch Med Wochenschr; 1984 Mar 02; 126(9):247-8. PubMed ID: 6425678
    [No Abstract] [Full Text] [Related]

  • 26. [Medical treatment of obliterating arteriopathies of the lower limbs with vasoactive drugs].
    Raspanti D, Cameli AM, Trapani M, Dorigo D, Mazzotta A, Negro P.
    Clin Ter; 1987 Jun 30; 121(6):479-83. PubMed ID: 2973884
    [No Abstract] [Full Text] [Related]

  • 27. Effects of buflomedil hydrochloride in occlusive arterial disease of the lower limbs stage IV.
    Briguglio F, Briguglio E, Di Marco V, Swat M, Materia G, Intilisano A.
    J Int Med Res; 1986 Jun 30; 14(3):115-23. PubMed ID: 3721052
    [Abstract] [Full Text] [Related]

  • 28. Pharmacological preconditioning of ischaemia.
    Laghi Pasini F, Capecchi PL, Acciavatti A, Petri S, de Lalla A, Cati G, Colafati M, Di Perri T.
    Clin Hemorheol Microcirc; 1997 Jun 30; 17(1):73-84. PubMed ID: 9181761
    [Abstract] [Full Text] [Related]

  • 29. [Effects of the administration of buflomedil-hydrochloride on the arterial circulation of the legs in patients with obliterative arteriopathies].
    Tallarida G, Baldoni F, Peruzzi G, Raimondi G, Grimaldi I, Visigalli G, Gristina S, Massaro M, De Martinis L, Sangiorgi M.
    Cardiologia; 1983 Aug 30; 28(8):651-60. PubMed ID: 6687209
    [No Abstract] [Full Text] [Related]

  • 30. [Ifenprodil tartrate in the treatment of occlusive arteriopathies of the lower limbs. Results of a prospective double-blind controlled multicenter trial].
    Natali J, Kieny R, Le Bas P, Benhamou M, Molkhou JM.
    Ann Cardiol Angeiol (Paris); 1989 Jun 30; 38(6):339-42. PubMed ID: 2667444
    [No Abstract] [Full Text] [Related]

  • 31. [Evaluation of the efficacy of medical treatment, especially anticoagulant treatment, in arteriopathies of the lower limbs. Apropos of 41 cases].
    Chérif T, Kallel N, Guediche M.
    Tunis Med; 1986 May 30; 64(5):475-80. PubMed ID: 3824555
    [No Abstract] [Full Text] [Related]

  • 32. [Double-blind randomized comparative study of nicergoline naftidrofuryl on the quality of life in chronic obliterative arteriopathy of lower limbs with intermittent claudication].
    Meilhac B, Montestruc F, Aubin F, Djian F, Rouffy J.
    Therapie; 1997 May 30; 52(3):179-86. PubMed ID: 9366101
    [Abstract] [Full Text] [Related]

  • 33. [Picotamide: use in chronic obliterative arteriopathies of the lower limbs].
    Tazza G, Tazza R, Valentini M, Leoni G, Avenia N, Ragusa M.
    Clin Ter; 1991 Jun 30; 137(6):399-402. PubMed ID: 1832611
    [Abstract] [Full Text] [Related]

  • 34. [Effects of proxazole on patients with obliterating arteriopathy of the lower limbs].
    Saponaro A, Russo R, Tomei F, Giordano M, Dragagna G, Barbato G.
    Clin Ter; 1979 Dec 31; 91(6):585-92. PubMed ID: 544162
    [No Abstract] [Full Text] [Related]

  • 35. [Comparison of 2 effective doses of Fludilat in peripheral vascular disorders in a double-blind trial].
    König FK.
    Med Welt; 1973 Sep 28; 24(39):1490-2. PubMed ID: 4588974
    [No Abstract] [Full Text] [Related]

  • 36. [Digital blood flow in peripheral vascular diseases. Action of drugs: buflomedil].
    Frausini G, Rotatori P, Gaggi S, Barone A, Pupita F.
    Minerva Cardioangiol; 1988 Jun 28; 36(6):319-22. PubMed ID: 3211330
    [No Abstract] [Full Text] [Related]

  • 37. Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.
    Diamantopoulos EJ, Grigoriadou M, Ifanti G, Raptis SA.
    Int Angiol; 2001 Dec 28; 20(4):337-44. PubMed ID: 11782701
    [Abstract] [Full Text] [Related]

  • 38. Effects of defibrotide on physical performance and hemorheologic picture in patients with peripheral arteriopathy.
    Marrapodi E, Leanza D, Giordano S, Nazzari M, Corsi C.
    Clin Trials Metaanal; 1994 Apr 28; 29(1):21-30. PubMed ID: 10150182
    [Abstract] [Full Text] [Related]

  • 39. Experience with buflomedil in peripheral arterial occlusive disease.
    Balas P, Pagratis N.
    Angiology; 1981 Oct 28; 32(10):679-85. PubMed ID: 7325404
    [No Abstract] [Full Text] [Related]

  • 40. [Treatment of chronic obliterative arteriopathy of the legs in the second Fontaine's stage. Personal experience with a buflomedil-pentoxifylline-defibrotide combination].
    Marci M, Albiani B, Ricci M, Russo F.
    Clin Ter; 1995 Mar 28; 146(3):211-4. PubMed ID: 7789083
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.